Andreessen Horowitz leads $22M in funding for Thyme care to improve patient outcomes, close gaps in health disparities, and drive value-based cancer care

By The Joplin Globe
| October 05, 2021

Thyme Care, an oncology care management solution providing high-touch, tech-enabled cancer care navigation, today announced it closed $22 million in funding led by Andreessen Horowitz, AlleyCorp, and Frist Cressey Ventures with participation from Casdin Capital and Bessemer. The capital will be used to accelerate Thyme Care’s technology and advance partnerships with oncologists, health plans, employers, and risk-based entities.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...